Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
Less common long-term risks include gallbladder disease and, rarely, pancreatitis
Its often the last chapter after bariatric weight loss
& Bird, G
Side Effects to Be Aware of When Beginning Treatment The most common side effects during retatrutide initiation are gastrointestinal, particularly nausea, and are generally dose-dependent and transient
Weinstock RS, Guerci B, Umpierrez G, Nauck MA, Skrivanek Z, Milicevic Z